Integramed America, Inc. (NASDAQ: INMD) reported Q2 EPS of $0.04, $0.10 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $76.19 million versus the consensus estimate of $76.05 million.

For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.

Earnings